Sign of Scorpio
The FDA has approved the use of scorpion-derived venom in human trials on brain cancer patients.
Really.
The re-engineered protein from the scorpion is mixed with a fluorescent molecule "flashlight;" the product, called “tumor paint,” illuminates tumors or areas so small a physician may be unable to detect them. It is the scorpion protein that binds to the cancer cells.
The first trial will be used on estimated 21 people with a glioma, or tumor in the brain or spine.
(S-R photo: A scorpion)